Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Danazol induced cholestasis: pathogenetic hypothesis

M Malaguarnera1, N Santangelo, M Motta

  • 1Institute of Internal Medicine and Geriatrics, University of Catania, Italy.

Panminerva Medica
|November 14, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Our experience with prurigo nodularis treated with dupilumab.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Ocular surface disease during dupilumab treatment in patients with atopic dermatitis, is it possible to prevent it?

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Cilostazol reduces dry eye symptoms and improve walking distance in patients with peripheral artery disease.

La Clinica terapeutica·2019
Same author

Possible role of polycyclic aromatic hydrocarbons in the onset of melanoma: preliminary data.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Scalp psoriasis: report of efficient treatment with secukinumab.

The Journal of dermatological treatment·2018
Same journal

Circulating osteopontin and body composition in systemic lupus erythematosus: a cross-sectional study.

Panminerva medica·2026
Same journal

Fluid de-resuscitation in critical illness: are we measuring the right endpoint?

Panminerva medica·2026
Same journal

A standardized Ferula supplement (Menotrack) to prevent symptoms in post-menopause: a 3-month supplement registry.

Panminerva medica·2026
Same journal

Impact of cardiogenic shock on outcomes in patients with spontaneous coronary artery dissection: a systematic review and meta-analysis.

Panminerva medica·2026
Same journal

Characteristics and outcomes of spontaneous coronary artery dissection versus Takotsubo Syndrome: a systematic review and meta-analysis.

Panminerva medica·2026
Same journal

Medical decluttering: what it is and why it is important.

Panminerva medica·2026
See all related articles

Danazol-induced cholestasis may stem from genetic changes in alpha-1 antitrypsin and P-glycoprotein, affecting bilirubin excretion. These alterations could explain variations in cholestasis severity and duration.

Area of Science:

  • Hepatology
  • Pharmacology
  • Genetics

Background:

  • Intrahepatic cholestasis can result from estrogen and steroid medications like danazol.
  • Mechanisms behind danazol-induced cholestasis are not fully understood.
  • Danazol stimulates alpha-1 antitrypsin synthesis and its metabolites interact with P-glycoprotein.

Purpose of the Study:

  • To hypothesize the role of genetic alterations in alpha-1 antitrypsin and P-glycoprotein in danazol-induced cholestasis.
  • To explain the variable presentation of danazol-induced cholestasis.

Main Methods:

  • Literature review and hypothesis formulation.
  • Analysis of known drug metabolism pathways and genetic factors.

Main Results:

Related Experiment Videos

  • Danazol's known effects on alpha-1 antitrypsin and P-glycoprotein substrates provide a basis for a new hypothesis.
  • Genetic variations in these proteins could impact bilirubin excretion.

Conclusions:

  • Genetic alterations in alpha-1 antitrypsin and P-glycoprotein may underlie danazol-induced cholestasis.
  • These genetic factors could account for the differing intensity and duration of cholestasis observed in patients.